Clarify, a vascular enhancement option for Siemens’ premium Antares ultrasound system, has been added to the StellarPlus Performance package. Clarify, which uses power Doppler blood flow data, minimizes noise to better visualize intricate networks of small blood vessels and reduce the steps needed to complete vascular studies.

No longer separate entities, the technologies of imaging and informatics are irreversibly linked. It is impossible for even the most modality-focused attendee who enters the technical exhibitions in McCormick Place not to recognize this. "Integrated RIS/PACS" is the buzzword of the day, replacing the ubiquitous "enterprise solution" of so many past years.

R2 Technology has unveiled at the RSNA meeting a robust version of computer-aided detection technology programmed to find colon polyps. The company plans to take this latest iteration of CAD, first shown at the 2002 RSNA meeting, to the FDA in next year.

R2 Technology has introduced at the RSNA meeting its new dual-mode ImageChecker, a single computer-aided detection unit that can process analog and digital mammography images simultaneously.

GE Medical Systems Lunar introduced the Applause, a portable MR device, at the RSNA meeting. The system is optimized for diagnosing early signs of joint erosion due to rheumatoid arthritis and other forms of autoimmune rheumatoid diseases.

The clinical argument for speed may be up in the air, but the technological one appears settled. At this year's RSNA meeting, Siemens, CTI, and Philips are ready with systems that deliver faster scans or more rapid image reconstructions. The RSNA exhibit hall also plays host to PET/CT's past and future, as the work-in-progress 16-slice version of GE's Discovery LS appears as a commercial product and CPS talks up-and may even show off-its multihead R&D platform.

Since multidetector CT scanners began rolling off the production line five years ago, CT anigography has become a routine procedure, in many cases the procedure of choice, for screening patients for arterial disease. The reason is the ease with which it can be applied. Patients can undergo CTA without being admitted to the hospital and without invasive catheter placement. An added benefit is the extraordinarily low cost of a scan compared with the gold standard x-ray angiography.

Language is less of a barrier now for prospective customers of iPACS, a Web-based PACS product from RealTimeImage. At SCAR, the company introduced multi-language support with an extended unicode character set for its iPACS product line. User interfaces

Women with a history of biopsy-proven lobular carcinoma in situ (LCIS) appear to benefit from the addition of MRI to mammography for annual breast cancer screening. A retrospective study from Memorial Sloan-Kettering Cancer Institute presented Sunday at the 2010 RSNA meeting indicates the application of screening MRI for this at-risk population can double the cancer detection rate.